Stefano Tarantini to Poly(ADP-ribose) Polymerase Inhibitors
This is a "connection" page, showing publications Stefano Tarantini has written about Poly(ADP-ribose) Polymerase Inhibitors.
Connection Strength
0.806
-
Treatment with the poly(ADP-ribose) polymerase inhibitor PJ-34 improves cerebromicrovascular endothelial function, neurovascular coupling responses and cognitive performance in aged mice, supporting the NAD+ depletion hypothesis of neurovascular aging. Geroscience. 2019 10; 41(5):533-542.
Score: 0.640
-
Effects of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Cerulein-Induced Pancreatitis. Shock. 2020 05; 53(5):653-665.
Score: 0.166